Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

WHO Classification of Tumours Editorial Board. Haematolymphoid tumours, 5th edn, vol. 11. Lyon (France): International Agency for Research on Cancer; 2024.

Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292–302.

Article  CAS  PubMed  Google Scholar 

Palomo L, Meggendorfer M, Hutter S, Twardziok S, Adema V, Fuhrmann I, et al. Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms. Blood. 2020;136:1851–62.

Article  PubMed  PubMed Central  Google Scholar 

Guru Murthy GS, Dhakal I, Mehta P. Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States. Leuk Lymphoma. 2017;58:1648–54.

Article  PubMed  Google Scholar 

Mangaonkar AA, Lasho TL, Ketterling RP, Reichard KK, Gangat N, Al-Kali A, et al. Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients. Blood cancer J. 2022;12:26.

Article  PubMed  PubMed Central  Google Scholar 

Vardell VA, Ose J, Rets AV, Tantravahi SK, Patel AB. Chronic Myelomonocytic Leukemia and Atypical Chronic Myeloid Leukemia: A National Analysis. Clin Lymphoma Myeloma Leukemia. 2024;24:843–51.

Wang SA, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D, et al. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood. 2014;123:2645–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elena C, Galli A, Such E, Meggendorfer M, Germing U, Rizzo E, et al. Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. Blood. 2016;128:1408–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

DiNardo CD, Daver N, Jain N, Pemmaraju N, Bueso-Ramos C, Yin CC, et al. Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy. Leukemia. 2014;28:958–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prakash S, Arber DA, Bueso-Ramos C, Hasserjian RP, Orazi A. Advances in myelodysplastic/myeloproliferative neoplasms. Virchows Arch. 2023;482:69–83.

Article  PubMed  Google Scholar 

Faria C, Tzankov A. Progression in Myeloid Neoplasms: Beyond the Myeloblast. Pathobiology. 2024;91:55–75.

Article  CAS  PubMed  Google Scholar 

Chen J, Kao YR, Sun D, Todorova TI, Reynolds D, Narayanagari SR, et al. Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level. Nat Med. 2019;25:103–10.

Article  CAS  PubMed  Google Scholar 

Ok CY, Trowell KT, Parker KG, Moser K, Weinberg OK, Rogers HJ, et al. Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1. Mod Pathol. 2021;34:20–31.

Article  CAS  PubMed  Google Scholar 

Zhang H, Wilmot B, Bottomly D, Dao KT, Stevens E, Eide CA, et al. Genomic landscape of neutrophilic leukemias of ambiguous diagnosis. Blood. 2019;134:867–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baumgartner F, Baer C, Bamopoulos S, Ayoub E, Truger M, Meggendorfer M, et al. Comparing malignant monocytosis across the updated WHO and ICC classifications of 2022. Blood. 2024;143:1139–56.

Article  CAS  PubMed  Google Scholar 

Selimoglu-Buet D, Wagner-Ballon O, Saada V, Bardet V, Itzykson R, Bencheikh L, et al. Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. Blood. 2015;125:3618–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Y, McKenna RW, Karandikar NJ, Pildain AJ, Kroft SH. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol. 2005;124:799–806.

Article  PubMed  Google Scholar 

Goasguen JE, Bennett JM, Bain BJ, Vallespi T, Brunning R, Mufti GJ, et al. Morphological evaluation of monocytes and their precursors. Haematologica. 2009;94:994–7.

Article  PubMed  PubMed Central  Google Scholar 

Foucar K, Hsi ED, Wang SA, Rogers HJ, Hasserjian RP, Bagg A, et al. Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study. Int J Lab Hematol. 2020;42:418–22.

Article  PubMed  Google Scholar 

Bernard E, Hasserjian RP, Greenberg PL, Arango Ossa JE, Creignou M, Tuechler H, et al. Molecular taxonomy of myelodysplastic syndromes and its clinical implications. Blood. 2024;144:1617–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia-Gisbert N, Arenillas L, Roman-Bravo D, Rodriguez-Sevilla JJ, Fernandez-Rodriguez C, Garcia-Avila S, et al. Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia. Leukemia. 2022;36:2922–6.

Article  CAS  PubMed  Google Scholar 

Komrokji RS, Komrokji Z, Al Ali NH, Xie Z, Chan O, Kuykendall AT, et al. CMML Is in the Eye of the Be_Who_ Lder: Interrogating the Newly Proposed Entity of Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML): MDS or CMML? Blood. 2024;144:1004–1004.

Article  Google Scholar 

Chapman J, Geyer JT, Khanlari M, Moul A, Casas C, Connor ST, et al. Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia. Mod Pathol. 2018;31:429–41.

Article  CAS  PubMed  Google Scholar 

Hu Z, Ramos CEB, Medeiros LJ, Zhao C, Yin CC, Li S, et al. Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis. Hum Pathol. 2019;85:290–8.

Article  CAS  PubMed  Google Scholar 

Vitte F, Fabiani B, Benet C, Dalac S, Balme B, Delattre C, et al. Specific skin lesions in chronic myelomonocytic leukemia: a spectrum of myelomonocytic and dendritic cell proliferations: a study of 42 cases. Am J Surg Pathol. 2012;36:1302–16.

Article  PubMed  Google Scholar 

Mathew RA, Bennett JM, Liu JJ, Komrokji RS, Lancet JE, Naghashpour M, et al. Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature. Leuk Res. 2012;36:72–80.

Article  PubMed  Google Scholar 

Qiao Y, Jian J, Deng L, Tian H, Liu B. Leukaemia cutis as a specific skin involvement in chronic myelomonocytic leukaemia and review of the literature: Acknowledgments. Transl Cancer Res. 2020;9:4988–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin de Fremont G, Hirsch P, Gimenez de Mestral S, Moguelet P, Ditchi Y, Emile JF, et al. Myeloid Clonal Infiltrate Identified With Next-Generation Sequencing in Skin Lesions Associated With Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: A Case Series. Front Immunol. 2021;12:715053.

Article  PubMed  PubMed Central  Google Scholar 

Enescu CD, Patel A, Friedman BJ. Unique Recognizable Histopathologic Variant of Palisaded Neutrophilic and Granulomatous Dermatitis that Is Associated With SRSF2-Mutated Chronic Myelomonocytic Leukemia: Case Report and Review of the Literature. Am J Dermatopathol. 2022;44:e33–e36.

Article  PubMed  Google Scholar 

Loghavi S, Sui D, Wei P, Garcia-Manero G, Pierce S, Routbort MJ, et al. Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories. Blood Adv. 2018;2:1807–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carreno-Tarragona G, Alvarez-Larran A, Harrison C, Martinez-Avila JC, Hernandez-Boluda JC, Ferrer-Marin F, et al. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes. Blood Adv. 2023;7:1672–81.